"Lead by our Board Certified Principal Investigator Dr. Mirel Sanchez, MD. Sanchez Clinical Research, Inc is an independent fast-growing Phase I-IV clinical research center, specializing in a diverse range of Family and Internal Medicine trials. Working closely with professional medical partners and associates, Sanchez Clinical Research is breaking new grounds in the pharmaceutical industry, making a significant contribution to the development of new life-saving treatments and medicines."

During the past decade, Sanchez Clinical Research, Inc conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanchez Clinical Research, Inc" #1 sponsor was "Shire" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanchez Clinical Research, Inc" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sanchez Clinical Research, Inc" are "Crohn's Disease" (4 trials), "Atopic Dermatitis" (3 trials), "Ulcerative Colitis" (3 trials), "Diabetes Mellitus" (1 trials) and "Gastroparesis" (1 trials). Many other conditions were trialed in "Sanchez Clinical Research, Inc" in a lesser frequency.

Most popular intervention types in "Sanchez Clinical Research, Inc" are "Drug" (12 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ontamalimab" (4 trials), "Lebrikizumab" (3 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanchez Clinical Research, Inc" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Sanchez Clinical Research, Inc". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Sanchez Clinical Research, Inc, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sanchez Clinical Research, Inc, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".